WeDoctor
微医
WeDoctor is a Chinese healthcare technology company that operates an online medical services platform. It was among the earliest investments for both 5Y Capital and HongShan (formerly Sequoia China), with 5Y Capital backing the company from a TMT angle at an early stage . The company has maintained partnerships with major tech and pharmaceutical players: it signed a strategic cooperation and cloud platform agreement with Tencent , and in early 2023 it launched a Hong Kong vaccination appointment service for AstraZeneca's Evusheld long-acting antibody combination . The company was recognized in 5Y Capital's portfolio lists alongside other high-growth enterprises such as Kuaishou, SenseTime, and XPeng .
AI-generated — may contain errors, please verify.
Coverage
January, Emergence, and Prologue | 5Y News Monthly
The big news from last month.
Trailblazers Carry Their Own Wind | 5Y News Monthly
The big news from last month.
Chuan Wang Can't Build a Doctor
Spending money on public welfare — that's greatness.
Faith is not an idea, but a way of life.｜5Y News Monthly
Major events from last month.
April: Growing Upward | 5Y News Monthly
The big news from last month.
Hongshan Healthcare Investing: 17 Years From the Sidelines to Center Stage
Going earlier and deeper has become a defining feature of Hongshan's healthcare investments.
February: Returning to Our Imagination of the World | 5Y News Monthly
The big news from last month.
Time forever forks, leading toward innumerable futures | 5Y News Monthly
The big news from last month.
June, Vitality | 5Y News Monthly
The big news from last month.
April: Imagination Is the Courage with Which We Face the World | 5Y News Monthly
The big news from last month.
March, Exploration and New Frontiers | 5Y News Monthly
The big news from last month.
The Rise and Fall of Education, Consumer Bubbles, Carbon Neutrality, Commercial Spaceflight... "Cool" Reflections on Hot Investment Topics | Li Feng Column
Exploring Opportunities Amid "Major Restructuring"
A Conversation with Qin Liu: An Investor Needs the Coolest Head and the Wildest Heart | 5Y Talk
Entrepreneurs of this era are a band of mad explorers.
5Y Capital's Xu Tian Jing: Why We're Bullish on Digital Pharmaceutical R&D | 5Y Talk
The ITBT track has a promising future ahead.
Morningside-backed LifeTech Scientific raises over RMB 1.2 billion in new funding round | Light Moments
China's new drug R&D is undergoing a "Cambrian explosion." The industry's underlying infrastructure for pharmaceutical innovation is one of the core sectors we're tracking in healthcare.
5Y Capital Completes First Close of New RMB Fund | Light Moments
Recently, 5Y Capital completed the first closing of its second RMB-denominated fund.
5Y Capital's Xutian Jing: ITBT Sector Has a Promising Future, Poised to Produce a New Breed of Pharma Companies with Strong Cash-Generation Capabilities | Light View
ITBT is a long game, but when it succeeds, its contribution to human society is immense.
The Triumph of Long-Termism: Morningside Recognized with Multiple Honors in 36Kr's "Most Founder-Friendly" and "Most LP-Trusted" Awards | Light Moments
On August 26, 36Kr's 2020 China Investor Future Summit was held in Shanghai, where the 2020 investment institution rankings were released, including:
Xpeng Motors' IPO: Key Moments We Know About | Light Moments
A new beginning, a new journey, a new chapter — congratulations to Xpeng Motors!
Morningside-backed XYZ Robotics closes nearly $20 million Series A+ round | Light Moments
Morningside-backed portfolio company XYZ Robotics has closed a nearly $20 million Series A+ round.
The Collision of AI and Pharmaceuticals: Galaxy Pharma Tech Raises Nearly $10 Million in Funding | Light Moments
Galixir announced the completion of a nearly $10 million Pre-A funding round. The round was co-led by Source Code Capital and DCM, with 5Y Capital participating as a follow-on investor. Gaorong Capital, the lead investor in the company's angel round, continued to increase its stake.
Morningside Partners with Agora to Launch RTE 2020 Startup Competition, Hunting for the Next Real-Time Internet Unicorn | Light View
Who will be the next unicorn in the real-time internet space? The RTE2020 Real-Time Internet Startup Challenge is waiting for you!
5Y Capital's Qin Liu and Fei Zhang Named to PEDaily's "TOP100 Investors" List | Light Moments
On August 12, PEDaily, China's professional portal for entrepreneurship and investment under Zero2IPO Group, jointly released with Zero2IPO Research the authoritative **2020 "Investment TOP100" investor ranking** — with Qin Liu, Founding Partner of 5Y Capital, and Fei Zhang, Partner of 5Y Capital, both making the list.
Tribute to the Unstoppable Force | Light View
A tribute to the unstoppable force.
